Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share 
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
Meta Expands AI Training With Employee Activity Tracking Tools 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs 
BETHLEHEM, Pa., May 16, 2017 -- B. Braun Medical Inc., an industry pioneer in offering products not made with PVC and DEHP, will showcase its portfolio of solution containers at the CleanMed 2017 Conference & Exposition on May 16-18 at the Minneapolis Convention Center.
“We’re focused on supplying a marketplace with an increasing demand for safe products,” said Rick Williamson, Vice President of Pharmaceutical and Drug Delivery Marketing at B. Braun. “We’re here for the long haul and making the investments to ensure that the healthcare industry is well served with quality medical supplies so clinicians can provide healing environments for their patients.”
In the past five years, B. Braun has spent more than $500 million in developing innovative ways to offer products not made with PVC and DEHP. B. Braun actively supports policies calling for the industry-wide reduction of these chemicals and natural rubber latex in medical devices to raise awareness and encourage change.
More than four decades ago, B. Braun recognized the environmental and patient risks posed by products containing PVC and DEHP. As a result, B. Braun was the first IV fluids manufacturer to remove these toxic substances from many products, and remains the only supplier that offers a full-line of IV solution containers that are not made with PVC or DEHP.
“B. Braun is committed to finding alternative methods to manufacture safer products, such as our TITAN™ XL irrigation bags and E3® IV containers,” Williamson said.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]
